Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Temperature excursions

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled.

569 FDA drug recalls with this cause, newest first.

Vaccines, insulin, many injectables and some tablets must stay within a narrow temperature band from factory to pharmacy. A truck without working refrigeration, a freezer failure or a warehouse heatwave is enough: the product looks normal but may have lost potency or formed degradation products. FDA files these under 'CGMP deviations' or 'temperature abuse'; we track them separately because the question to ask - how was my medication stored? - is different from every other cause.

Class II · Moderate risk

Amiodarone HCl Injection

Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.

Terminated Temperature excursion Mckesson NDC 67457-153-09 D-0005-2015
Class II · Moderate risk

Benicar HCT Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-107-30 D-1508-2014
Class II · Moderate risk

Benicar HCT Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-106-30 D-1507-2014
Class II · Moderate risk

Benicar Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-104-30 D-1506-2014
Class II · Moderate risk

Welchol Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-701-18 D-1505-2014
Class II · Moderate risk

Tribenzor Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-116-30 D-1504-2014
Class II · Moderate risk

Benicar HCT Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-105-30 D-1503-2014
Class II · Moderate risk

Benicar Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-103-30 D-1502-2014
Class II · Moderate risk

Azor Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-113-30 D-1501-2014
Class II · Moderate risk

HydrOXYzine Hydrochloride Oral Solution

Failed Impurity/Degradation Specification; out-of-specification result for one individual unknown impurity at the 24-month room temperature stability test station.

Terminated Temperature excursion Hi-Tech Pharmacal Co., Inc. NDC 50383-796-16 D-0048-2015
Class III · Low risk

Bumetanide Tablets USP 0.5 mg. Rx Only

Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.

Terminated Temperature excursion Sandoz Inc D-341-2014
Class II · Moderate risk

Ifosfamide Injection 3g/60 mL

Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.

Terminated Temperature excursion AmeriSource Bergen NDC 0069-4496-22 D-1066-2013
Class II · Moderate risk

Ifosfamide Injection 1g/20mL

Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.

Terminated Temperature excursion AmeriSource Bergen NDC 0069-4495-22 D-1065-2013